In fasting rats, intraduodenal infusion of dilute hydrochloric acid results in significant increases in both 
the upper small intestine produced a greater amount of pancreatic juice than when pancreatic juice was allowed to enter the duodenum (1) . They suggested that the increased pancreatic secretion might have resulted from increased release of secretin (1) . In fasting rats, Green and Lyman (2) observed that diversion of pancreatic juice from the upper small intestine resulted in increased pancreatic exocrine secretion and infusion of either pancreatic juice or trypsin into the duodenum reversed the increase. They suggested that the increase in pancreatic secretion was attributed to increased release of cholecystokinin (CCK) (2) . In recent years, this original observation in rats was confirmed by several groups of investigators (3) (4) (5) . It has been found that the increased pancreatic secretion was due to increased release of not only CCK (3) (4) (5) but also secretin (6) . However, when the increase in pancreatic secretion was reversed by either pancreatic juice or trypsin in the duodenum, the increases in plasma concentration of CCK (3) (4) (5) and secretin (6) were also abolished in rats. Recently, in rats, it was learned that the increases in both pancreatic exocrine secretion and plasma concentrations of secretin and CCK in response to intraduodenal administration of sodium oleate was suppressed significantly by either pancreatic juice or a combination of both trypsin and chymotrypsin (7) . However, interestingly, in similar experiments in dogs (8) , pancreatic juice or trypsin caused significant decreases in both pancreatic secretion and plasma concentration of secretin but no decrease of CCK.
These observations in rats and dogs suggest that there is a trypsin-sensitive releasing factor in the upper small intestine that stimulates the release of secretin. A releasing factor for secretin was searched for in the upper small intestinal perfusate while duodena were infused with a dilute hydrochloric acid in anesthetized rats. Hydrochloric acid is a well-recognized stimulant for the release of secretin in many species (9, 10) . In the present investigation, a secretin-releasing peptide was found in the upper small intestinal perfusate in rats.
Materials and Methods Animal preparation
Male Sprague-Dawley rats weighing between 230 and 300 g were fasted for 24 h with free access to drinking water before surgery. Under anesthesia with 0.35 ml of 25% urethane per 100 g ofbody weight given intraperitoneally, followed by subcutaneous injection of urethane in the same dose, a midline abdominal incision was made. A polyethylene tube (ID 3.0 mm, OD 4.0 mm) was inserted into the proximal duodenum 5 mm distal to the pylorus via the stomach followed by ligation of the pylorus for intraduodenal infusion of 0.01 N HCI, 0.15 M NaCl or intestinal perfusates (Fig. 1) . A polyethylene tube (PE-IO, ID 0.28 mm, OD 0.61 mm) was inserted into the pancreatic duct at the junction between the bile-pancreatic duct and the duodenal wall for collection of pancreatic juice. Another PE-10 tube was inserted into the bile duct proximal to the pancreatic duct for diversion ofbile to the exterior. An additional cannula was placed into the jejunum 15 cm distal to the ligament of Treitz for collection of perfusates (Fig. 1) . 
Experimental procedures
Measurement of pancreatic secretion and plasma concentrations of secretin and CCK in response to dilute HCl, isotonic saline, and a combination of dilute HCl and NaHCO3, and collection of intestinal perfusates: 10 min after surgery each rat received intraduodenal infusion of 0.15 M NaCI at a rate of0. supernates were 1yophilized. The dried material was reconstituted in H20 to make a threefold concentrate with pH adjusted to 6.0 with 1 N NaOH before it was reinfused into the duodena of recipient rats as described below. At the end of the infusion with either one of these solutions for 1.5 h, blood was drawn from the abdominal aorta. Plasma was separated by centrifugation at 1,000 g and40C for 15 min, mixed with a cocktail of various protease inhibitors to final concentrations of 100 lug/ml of soybean trypsin inhibitor, 1.5 .g/ml of bovine pancreatic trypsin inhibitor, and 9.9 X 10-9 M of D-Phe-L-Phe-L-Arg CH2 Cl2 and stored at -20°C before radioimmunoassay for secretin and CCK (11) (12) (13) .
Bioassay ofconcentrated perfusates: To determine the effect of the concentrated perfusate on pancreatic exocrine secretion and the release of secretin and CCK, three groups of seven rats each were prepared with upper small intestinal cannulas as described above (Fig. 1) .
After initial 1.5 h of perfusion with 0.15 M NaCl, the threefold concentrate of acid perfusate (CAP), saline perfusate (CSP), or a combined acid and sodium bicarbonate perfusate (CABP) was infused into the duodenum at 0.3 ml * min-' for 1.5 h (Fig. 1, groups 1-3) . To study the effect of a rabbit antisecretin serum on the action of CAP, another two groups of five recipient rats each received intravenous injection of either 0.1 ml of a rabbit antisecretin serum or a normal rabbit serum 15 min before CAP was administered ( Fig. 1 , groups 4 and 5). To determine the properties of CAP, it was incubated with bovine crystalline trypsin (Worthington Biochemical Co., Freehold, NJ), 100,ug/ml, at 37°C for 1 hand then boiled for 15 min to destroy the enzyme activity, or CAP was boiled for 15 min without incubation with trypsin. Thus, in another two groups of seven rats each, either trypsin-treated CAP or boiled CAP was infused into the duodenum at a rate of 0.3 ml * min' as described above (Fig. 1 , groups 6 and 7).
Estimation ofmolecular weight ofsecretin-releasingfactor: To estimate the molecular weight of the active substance in the perfusate, the acid perfusate collected from the upper small intestine was adjusted to pH 6.0, boiled for 15 min and ultrafiltrated through various Amicon membranes (W. R. Grace and Co., Danvers, MA). The materials were first filtered through a PM-10 membrane (molecular weight cut off = 10,000). The material retained by the membrane (mol wt> 10,000) was invariably inactive in stimulating pancreatic secretion in several experiments (data not shown). The active material filtered through the membrane was further fractionated by filtering through a YM-5 membrane (molecular weight cut off = 5,000). The filtrate of YM-5 membrane was further filtered through a YM-2 membrane (molecular weight cut off = 1,000). The materials retained by YM-5 membrane (mol wt, 5,000-10,000) and by a YM-2 membrane (mol wt, 1,000-5,000), and filtrate of YM-2 membrane (mol wt < 1,000) were concentrated threefold and infused into the upper duodenum at 0.3 ml -min-' for 1.5 h in three groups of five rats each (Fig. 1 ,
Measurement ofpancreatic exocrine secretion and release ofsecretin: Pancreatic juice was collected continuously by a glass micropipette (Drummond Scientific Co., San Francisco, CA) in 30-min samples. The volume of pancreatic flow was measured by calculating the length of pancreatic juice in the micropipette with a capacity of 3.85 l-cm-' tube length. The minimal detectable volume change was 0.5 mm, i.e., 0.2 Al. 10 il of the pancreatic juice was immediately blown into an ice-chilled covered test tube and diluted twice with H20 for determination of bicarbonate concentration using a chloride/carbon dioxide analyzer (Beckman Instruments, Inc., Fullerton, CA). The minimally detectable amount of bicarbonate was 0.05 MEq. The result was expressed as microequivalents per 30 min. At the end of each experiment blood samples were drawn immediately from the aorta and collected into ice-chilling heparinized glass tubes. Plasma was obtained as described above.
Determination ofduodenalpH and trypsin activity: Five conscious rats each weighing -300 g were prepared with a stainless cannula (without pancreatic duct cannulation device) placed in either proximal duodenum (1.0 cm distal to the pylorus) or distal duodenum (5.0 cm distal to the pylorus) as described previously (14) . After 24 h fast, the animals were placed in Bollman cage. Duodenal contents were collected continuously through the cannulas in both fasting and postprandial state. To collect duodenal contents during postprandial period, rats were fed with Purina rat chow in an average amount of 1.1 g in 5 min. Duodenal contents were collected continuously for two consecutive 30 min. pH of the liquid portion of the duodenal contents was determined using a pH meter 145 (Corning Medical and Scientific, Meadfield, MA). Trypsin activity of the duodenal contents was determined by the method of Hummel (15) .
Effect of exogenous secretin in the duodenal lumen on pancreatic secretion and plasma secretin: To determine if secretin in the duodenal lumen can affect pancreatic exocrine secretion and/or plasma secretin level in 24 h fasted anesthetized rats, porcine secretin in three different concentrations including 2,5, and10 nM dissolved in 0.2% BSA saline solution was administered intraduodenally via a polyethylene tube (PE-90). Pancreatic juice was collected for 1.5 h as described above. Blood was collected by aortic puncture at the end of secretin administration. The doses of secretin used in this study were similar to the secretin content found in CAP (2.6 nM).
Statistical analysis
All results were expressed graphically as means±SE. The changes in pancreatic volume flow and bicarbonate output were expressed as percentage increase over basal values during the last 30-min period. Student's t test was used to analyze data. Statistical significance was set at P < 0.05.
Results
Pancreatic secretion andplasma concentrations ofsecretin and CCK in response to intestinal perfusion in donor rats: Upper intestinal perfusion of 0.01 N HCl resulted in a significant increase in pancreatic exocrine secretion which included both volume flow and bicarbonate output, and plasma concentration of secretin (Fig. 2) . In contrast, neither pancreatic secretion nor plasma concentration of secretin was influenced by the perfusion of 0.15 M NaCl or a combined solution of 0.01 N HC1 and 0.05 N NaHCO3. Plasma concentration of CCK was not influenced by either one of the three testing solutions.
Effects ofconcentrated upper intestinalperfusate on pancreatic secretion and the release ofsecretin and CCK in recipient rats: In each group of rats, pancreatic volume flow and bicarbonate output were stable during 1.5-h period with intraduodenal infusion of 0.15 M NaCl. Subsequent intraduodenal administration of CAP significantly increased pancreatic secretion including both volume flow and bicarbonate output by 99.9±16.1% and 183.2±36.3%, respectively, compared with the basal values (P < 0.01) (Fig. 3, A and B) . However, intraduodenal infusion of CSP or CABP failed to increase significantly pancreatic exocrine secretion. After the infusion of CAP, plasma secretin concentration was 6.2 pM which was higher significantly than plasma secretin concentration after the infusion of CSP or CABP (P < 0.05) (Fig. 4) . There was no change in plasma concentration of CCK in response to either one of these three perfusates (data not shown).
Effect of a rabbit antisecretin serum on CAP-stimulated pancreatic secretion and plasma secretin concentration: Intravenous injection of the antisecretin serum completely abolished the CAP-stimulated pancreatic volume flow and bicarbonate output (Fig. 5, A and B) and the increase in plasma secretin (Fig. 6 A) , whereas a normal rabbit serum (NRS) did not affect either pancreatic secretion or plasma secretin (Fig. 5,  A and B, and 6 A).
Partial characterization ofsecretin-releasing factor (S-RF) in CAP: Intraduodenal perfusion of CAP as incubated with trypsin and followed by boiling resulted in a significant sup-100.. pression of both plasma secretin levels (Fig. 6 B) and pancreatic secretion which included volume flow and bicarbonate output (Fig. 7, A and B) in seven rats. In contrast, CAP boiled for 15 min did not change the stimulatory action of CAP on the release of secretin (Fig. 6 B) or pancreatic exocrine secretion (Fig. 7, A and B) . The molecular weight of S-RF in CAP was estimated by ultrafiltration through various Amicon membranes as described in Methods. As shown in Fig. 8 , only the material with mol wt 1,000-5,000 increased significantly pancreatic volume flow and bicarbonate output by 81.0±20.2% and 166.0±54.2% (P < 0.05), respectively. Plasma secretin concentration was also increased to 4.8±0.6 pM. The materials with mol wt 5,000-10,000 and mol wt < 1,000 were inactive (Fig. 8) . 1 results indicate that S-RF is a heat-stable polypeptide sen to trypsin and has a molecular weight of 1,000-5,000.
Duodenal pH and trypsin activity ofthe duodenal conl
In five conscious rats, pH of the luminal contents of pro) tents.
or distal duodenum in fasting and postprandial state are deKimal scribed in Table 1 . In fasting state, pH in both proximal and distal duodenum was 7.1. During postprandial state, the mean pH in the proximal duodenum decreased to -2.4, whereas in the distal duodenum it was 7.1 or greater. The trypsin activity paralleled the pH values: in fasting state with duodenal pH 7.0, trypsin activity was high, whereas it was very low when luminal pH was low in the proximal duodenum during postprandial period. At the distal duodenum, trypsin activity was high as pH was 7.0 or higher.
Effect ofintraduodenal secretin on pancreatic secretion and release ofsecretin: As depicted in Table 2 , secretin given intraduodenally in concentrations up to 10 nM did not increase plasma concentration of secretin, whereas CAP increased secretin to the level of 6.6 pM. The volume flow and bicarbonate output paralleled the increase in the secretin level. Although secretin has been known to exist in the upper small intestinal mucosa and to stimulate pancreatic exocrine secretion since the turn of this century (9) , only in the past decade has it been firmly established that secretin is a circulating hormone that increases significantly in the circulation in response to ingestion of a meal (16) (17) (18) . During the postprandial period, the major factor that stimulates the release of secretin is hydro- aS.
a6. (25) . Like S-RP the peptide is also heat stable and trypsin sensitive (24, 25) . The molecular size appears to be small, < 3,000 D (24) . Whereas their cholecystokinin-releasing peptide stimulates the release of cholecystokinin, the one found in the present study specifically releases secretin. It is not known whether or not S-RP is released spontaneously into the upper small intestinal lumen. Because it was observed previously that diversion ofpancreatic juice from the upper small intestine during interdigestive state resulted in significant increases in both plasma secretin concentration and pancreatic exocrine secretion (6) , spontaneous release of S-RP is likely. A study is in progress to clarify this possibility. Nevertheless, secretin appears to be another intestinal hormone that has a significant importance on enteropancreatic feedback regulation of exocrine pancreas, specifically secretion of bicarbonate. Moreover, one of the factors responsible for the release of secretin by duodenal acidification may be an S-RP.
